Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-347932
Filing Date
2012-08-09
Accepted
2012-08-09 17:15:02
Documents
12
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d344794d10q.htm 10-Q 363314
2 EX-3.1 d344794dex31.htm EX-3.1 66944
3 EX-31.1 d344794dex311.htm EX-31.1 7344
4 EX-31.2 d344794dex312.htm EX-31.2 7326
5 EX-32.1 d344794dex321.htm EX-32.1 4480
6 EX-32.2 d344794dex322.htm EX-32.2 4523
  Complete submission text file 0001193125-12-347932.txt   2734323

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mnov-20120630.xml EX-101.INS 251904
8 XBRL TAXONOMY EXTENSION SCHEMA mnov-20120630.xsd EX-101.SCH 31912
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mnov-20120630_cal.xml EX-101.CAL 48214
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnov-20120630_def.xml EX-101.DEF 59544
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnov-20120630_lab.xml EX-101.LAB 252262
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnov-20120630_pre.xml EX-101.PRE 172132
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 950 SAN DIEGO CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 950 SAN DIEGO CA 92122 858-373-1500
MEDICINOVA INC (Filer) CIK: 0001226616 (see all company filings)

EIN.: 330927979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33185 | Film No.: 121021508
SIC: 2834 Pharmaceutical Preparations